Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
The number of people worldwide suffering from Alzheimer’s disease (AD) and type 2 diabetes (T2D) is on the rise. Amyloid polypeptides are thought to be associated with the onset of both diseases. Amyloid-β (Aβ) that aggregates in the brain and human islet amyloid polypeptide (hIAPP) that aggregates...
Main Authors: | Taisei Tanaka, Vipul V. Betkekar, Ken Ohmori, Keisuke Suzuki, Hideyuki Shigemori |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/11/1118 |
Similar Items
-
Fibril elongation by human islet amyloid polypeptide is the main event linking aggregation to membrane damage
by: Barend O.W. Elenbaas, et al.
Published: (2023-01-01) -
Studies on alpha-synuclein and islet amyloid polypeptide interaction
by: Ye Wang, et al.
Published: (2023-01-01) -
Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ
by: Raliat O. Abioye, et al.
Published: (2022-02-01) -
Electrochemical Assay of Human Islet Amyloid Polypeptide and Its Aggregation
by: Genxi Li, et al.
Published: (2008-09-01) -
Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)